inspir
bioactiv
biarylcontain
natur
product
found
plant
marin
environ
seri
synthet
compound
belong
azabinol
chiral
ligand
famili
evalu
antivir
activ
test
uniqu
azabinol
round
infect
assay
result
identif
three
promis
antivir
compound
includ
quinolin
azabinol
b
exhibit
micromolar
activ
activ
compound
sever
close
structur
analogu
test
three
differ
envelop
pseudotyp
virus
well
fullviru
replic
system
easyhit
modeofact
studi
use
timeofaddit
assay
indic
azabinol
b
act
viral
entri
viral
assembl
bud
revers
transcriptas
rt
assay
individu
test
polymeras
rnase
h
activ
use
demonstr
b
inhibit
rnase
h
activ
like
alloster
bind
analysi
use
biolay
interferometri
bli
show
b
interact
rt
highli
specif
manner
result
indic
azabinol
b
potenti
viabl
novel
hivaid
continu
major
global
health
epidem
million
axial
chiral
dimer
naphthylisoquinolon
alkaloid
first
isol
anicistrocladu
korupensi
later
name
michellamin
exhibit
select
antihiv
activ
given
fact
taken
togeth
exist
antivir
biaryl
natur
product
eg
dioncophyllin
recent
identifi
synthet
antivir
drug
lead
multipl
aromat
ring
system
eg
arbidol
peptid
triazol
rhodanin
deriv
naphthylhydrazon
hydroxypyridon
elect
test
librari
heterocycl
biaryl
compound
avail
us
belong
socal
azabinol
chiral
ligand
famili
inhibit
azabinol
nitrogen
analog
binol
base
isostructur
yl
quinolin
molecul
focu
interest
fundament
standpoint
potenti
util
enantioselect
synthesi
prior
work
studi
aspect
biolog
activ
azabinol
yet
report
herein
show
deriv
provid
novel
scaffold
inhibit
rt
rnase
h
activ
lead
compound
isopropyl
ether
deriv
b
show
unoptim
low
micromolar
activ
rang
hiv
singl
round
infect
assay
well
fulli
infecti
viral
assay
low
cytotox
select
index
type
particl
differ
tropism
includ
tabl
six
azabinol
compound
show
similar
activ
across
viral
variant
quinoltyp
ether
b
particular
show
low
micromolar
neutral
strain
test
activ
similar
antivir
drug
abacavir
although
naphtholtyp
ether
b
show
minor
antivir
activ
high
concentr
greater
concentr
test
significantli
larger
comparison
close
relat
quinoltyp
ether
b
valu
signific
differ
antivir
activ
two
regioisom
b
b
hint
toward
highli
specif
select
mode
inhibit
correspond
carbam
deriv
b
b
show
moder
antivir
activ
three
viral
strain
smaller
select
indic
neither
deriv
b
b
show
antivir
activ
concentr
next
use
easyhit
full
viral
infect
assay
system
test
six
isopropyl
ether
carbam
azabinol
deriv
fullyinfecti
replic
compet
tabl
quinoltyp
ether
b
continu
exhibit
low
micromolar
antivir
activ
easyhit
assay
system
accord
result
obtain
hivpp
assay
surprisingli
naphtholtyp
ether
b
exhibit
increas
antivir
activ
carbam
deriv
b
b
gave
similar
high
micromolar
viral
neutral
also
display
compar
cytotox
analog
compound
b
b
show
antivir
activ
cytotox
concentr
test
uniqu
compound
origin
screen
activ
one
compound
quinoltyp
ether
b
stand
select
antivir
activ
favor
select
index
small
chang
structur
includ
move
isopropyl
ether
substitu
naphthyl
ring
system
b
introduct
addit
aromat
bound
nitrogen
atom
b
result
drastic
reduc
antivir
activ
azabinol
carbam
deriv
b
b
exhibit
antivir
activ
phenotyp
assay
also
show
signific
cytotox
therefor
appar
antivir
activ
like
due
interfer
cellbas
assay
low
micromolar
antivir
activ
lead
compound
b
encourag
us
explor
modeofact
promiscu
inhibitor
highthroughput
screen
endeavor
often
lead
unproduct
identif
develop
compound
nonspecif
activ
exampl
base
assay
requir
colorimetr
outread
inhibit
nonspecif
mechan
give
falseposit
result
cellbas
hivpp
use
studi
contain
luciferas
report
read
look
test
capac
b
directli
inhibit
luciferas
luminesc
recombin
luciferas
enzym
test
si
figur
b
show
inhibit
luciferas
activ
quench
concentr
test
verifi
act
luminesc
addit
base
low
solubl
larg
hydrophob
surfac
area
b
sought
probe
abil
inhibit
unspecif
aggreg
effect
test
abil
b
aggreg
higher
concentr
aqueou
condit
via
hnmr
dilut
studi
si
figur
five
concentr
b
test
mm
phosphat
buffer
made
chang
seen
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
singl
round
infect
assay
use
envelop
pseudotyp
virus
abl
report
inhibit
earli
stage
infect
includ
cell
entri
revers
transcript
integr
step
activ
azabinol
compound
b
inhibit
strain
test
regardless
differ
viral
tropism
broad
inhibit
indic
antivir
modeofact
unlik
reli
viral
fusion
process
chang
surfac
glycoprotein
affect
antivir
activ
addit
easyhit
temsavir
lose
activ
dose
post
viral
entri
instead
b
remain
activ
throughout
assay
exhibit
subtl
decreas
antivir
activ
hour
post
infect
next
sought
explor
viral
enzym
interact
directli
verifi
b
interact
hiv
rt
dual
function
dna
polymeras
andor
rnase
h
activ
hiv
integras
nnrti
bind
hiv
rt
enzym
occur
distant
alloster
bind
site
longdist
effect
rt
polymeras
activ
well
document
contrast
inhibitor
hiv
rt
enzym
target
rnase
h
function
directli
affect
catalyt
side
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
mg
ion
therefor
often
dual
inhibitor
effect
revers
transcriptas
integras
requir
bival
metal
activ
site
screen
b
inhibitori
activ
recombin
proteinbas
assay
test
rt
andor
integras
antivir
inhibit
tabl
azabinol
b
show
effect
integras
activ
commerci
avail
kit
expressbio
frederick
md
concentr
test
test
rt
polymeras
assay
observ
weak
inhibitori
effect
b
concentr
higher
sever
order
magnitud
weaker
seen
cellbas
assay
howev
sinc
rnase
h
activ
second
catalyt
activ
revers
transcriptas
detect
rtpolymeras
assay
investig
effect
b
rnase
h
activ
use
previous
report
fret
base
approach
use
pair
oligonucleosid
includ
strand
rna
contain
modif
strand
dna
quencher
modif
rna
cleav
rnadna
hybrid
rnase
h
activ
fluoresc
probe
remov
quench
partner
dabcyl
result
fluoresc
found
b
inhibit
rnase
h
activ
hiv
rt
within
rang
low
micromolar
cellbas
assay
result
inhibitor
therefor
allow
favor
therapeut
window
show
b
inhibit
rnase
h
activ
bind
revers
transcriptas
enzym
explor
direct
bind
immobil
rt
use
biolay
interferometri
bli
bli
allow
real
time
measur
bind
affin
ligand
analyt
vari
size
use
singleus
fiber
optic
sensor
bli
measur
associ
kon
dissoci
koff
rate
directli
full
spectrum
wavelength
shift
associ
interfer
pattern
chang
deriv
bind
event
sensor
tip
determin
bind
affin
kd
recombinantwild
type
rt
nih
aid
reagent
immobil
via
amin
coupl
onto
bli
biosensor
b
select
azabinol
control
compound
rilpivirin
posit
control
raltegravir
neg
control
prepar
kinet
buffer
multipl
concentr
compound
test
multipl
concentr
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
respons
global
fit
use
bind
model
fit
use
calcul
kd
valu
bind
curv
obtain
b
shown
figur
good
agreement
cellbas
antivir
assay
b
show
concentrationdepend
bind
rt
control
compound
rilpivirin
also
show
concentr
depend
bind
curv
raltegravir
integras
inhibitor
show
bind
concentr
test
expect
si
figur
although
acquir
kd
associ
b
higher
cellbas
assay
note
affin
valu
directli
relat
neutral
efficaci
seen
mani
highaffin
nonneutr
hiv
antibodi
bind
observ
relat
azabinol
interest
compound
librari
si
figur
summari
bli
bind
data
obtain
reveal
strike
correl
bind
affin
b
toward
target
hiv
rt
antivir
activ
rnase
h
inhibit
rt
explor
underutil
mechan
inhibit
azabinol
compound
report
repres
novel
scaffold
inhibit
hiv
via
underexplor
alloster
mechan
low
toxic
high
specif
particular
isopropyl
ether
deriv
b
exhibit
potent
specif
antivir
activ
hiv
rnase
h
util
timeofaddit
experi
recombin
enzym
assay
show
b
specif
inhibit
rnase
h
addit
use
bli
show
b
bind
hiv
rt
via
bind
mechan
bind
affin
kd
although
number
azabinol
compound
within
screen
librari
found
limit
solubl
cellbas
assay
expect
aggreg
specif
inhibit
test
thoroughli
dismiss
lead
compound
b
si
fig
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
futur
studi
plan
optim
azabinol
core
structur
increas
activ
improv
bind
solubl
reduc
cytotox
anticip
absolut
configur
biaryl
system
influenc
biolog
activ
extent
remain
open
question
sinc
major
compound
evalu
herein
test
racem
form
work
progress
determin
configur
stabil
compound
b
bioassay
materi
enantioenrich
form
conduct
racem
halfliv
prove
high
enough
effort
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
summari
discov
isopropyl
ether
deriv
azaanalog
archetyp
axial
chiral
biaryl
ligand
binol
inhibit
infect
vitro
base
identifi
rnase
h
inhibit
direct
rt
bind
known
hydrophob
bind
surfac
associ
alloster
inhibiton
believ
b
novel
alloster
inhibitor
rtrnase
h
activ
biaryl
compound
natur
origin
long
known
exhibit
signific
biolog
activ
studi
suggest
investig
bioactiv
artifici
biaryl
design
pure
synthet
util
mind
warrant
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
follow
tlc
analysi
use
silica
gel
plate
fluoresc
indic
nm
visual
uv
phosphomolybd
acid
pma
noncommerci
avail
binol
azabinol
compound
test
previous
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
stir
h
time
mixtur
allow
cool
rt
partit
etoac
ml
ml
sat
aq
ml
aqueou
phase
extract
etoac
ml
combin
organ
phase
wash
ml
brine
ml
dri
concentr
vacuo
pseudotyp
virus
prepar
previous
describ
briefli
hek
cell
transfect
envelop
express
plasmid
envelop
defici
backbon
vector
use
xtremegen
hp
dna
transfect
reagent
roch
hour
incub
growth
media
replac
fresh
media
follow
addit
hour
incub
cellular
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
resazurin
measur
use
fluoresc
micropl
reader
excit
filter
wavelength
nm
emiss
filter
wavelength
nm
gain
understand
mechan
action
antivir
azabinol
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
antivir
azabinol
b
assess
inhibit
revers
transcriptas
use
commerci
avail
colorimetr
revers
transcriptas
assay
kit
roch
accord
manufactur
instruct
valu
determin
dilut
seri
run
triplic
normal
percentag
inhibitori
activ
calcul
use
posit
neg
control
well
set
amount
vehicl
solvent
dmso
fret
base
assay
assess
rnase
h
inhibit
rt
use
previous
sodium
azid
bind
affin
kd
character
analysi
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
associ
dissoci
curv
multipl
concentr
sampl
test
duplic
rilpivirin
use
posit
bind
control
raltegravir
neg
control
effect
nonspecif
bind
remov
use
doubl
referenc
residu
baselin
drift
calcul
fit
respons
baselin
period
exponenti
decay
subtract
drift
result
respons
curv
global
fit
langmuir
model
fit
perform
use
constrain
nonlinear
least
squar
minim
matlab
lsqnonlin
function
implement
trust
region
reflect
algorithm
constraint
paramet
use
guid
converg
away
nonphys
paramet
valu
constraint
inact
converg
optimum
parametr
bootstrap
analysi
use
comput
confid
interv
comput
kd
valu
use
normallydistribut
error
varianc
estim
sum
squar
residu
model
fit
matlab
iter
random
nois
respons
curv
filter
prior
plot
use
smooth
spline
matlab
spap
function
test
complex
b
mg
ion
carri
follow
previou
protocol
adjust
brief
stock
solut
solut
b
prepar
ethanolacetonitril
mixtur
b
dilut
uv
absorb
read
record
use
biotek
synergi
plate
reader
nm
addit
mm
mg
solut
contain
b
keep
compound
concentr
consist
ad
stepwis
follow
absorb
read
addit
concentr
mg
rais
addit
mm
mm
align
refer
subtract
blank
plot
done
raw
data
use
microsoft
excel
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
determin
b
capabl
nonspecif
inhibit
luciferas
activ
pseudotyp
assay
implement
cellfre
assay
purifi
recombin
luciferas
promega
luciferin
brightglo
luciferas
assay
system
promega
follow
previou
protocol
protein
reagent
prepar
store
accord
manufactur
instruct
preliminari
experi
establish
concentr
luciferin
use
assay
order
close
mimic
protein
signal
singleround
infect
assay
give
maxim
sensit
luminesc
read
reaction
carri
white
wellplat
gibco
thermofish
scientif
combin
compound
recombin
luciferas
pb
buffer
mgml
bsa
vwr
reaction
initi
addit
luciferin
substrat
well
luminesc
read
immedi
record
normal
use
appropri
control
vehicl
solvent
dmso
compound
luciferas
inhibitor
vwr
raltegravir
nih
aid
reagent
program
use
posit
neg
control
respect
observ
precipit
azabinol
compound
concentr
higher
cell
media
dmso
assess
antivir
activ
activ
azabinol
compound
b
could
due
nonspecif
aggreg
effect
hnmr
assay
implement
character
compound
behavior
aqueou
condit
describ
previous
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
mhz
spectromet
equip
tci
cryoprob
data
analyz
plot
use
bruker
topspin
softwar
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
supplementari
data
addit
nmr
data
figur
illustr
compound
librari
antivir
screen
protein
assay
result
bli
control
data
assess
nonspecif
inhibit
associ
articl
found
onlin
version
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
